| • |
Safety review of CRFs in house by qualified personnel |
| • |
Full reporting of SAEs following each Sponsor’s safety reporting SOPs and |
| |
systems |
| • |
Timely follow-up of all SAEs in close collaboration with all related parties |
| • |
Complete pharmacovigilence services through collaboration with external specialists |
